(Total Views: 879)
Posted On: 04/19/2020 2:40:35 PM
Post# of 154120
I received an answer to my email two weeks ago regarding access to leronlimab for Boris Johnson. Not a yes or a no, just a solid maybe?...
RE: CSC 2028 - Boris Johnson - COVID-19
Inbox
x
MHRA Customer Services <MHRACustomerServices@mhra.gov.uk>
7:01 AM (4 hours ago)
to me
Our Reference: CSC 2028
Dear MJL,
Thank you for providing this information.
Decisions on the use of unlicensed medicine for treatment of patients is made by the healthcare professionals who will decide best treatments going forward for their patient based on their judgement and they do so on their own responsibility.
Kind Regards
Peter
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000
RE: CSC 2028 - Boris Johnson - COVID-19
Inbox
x
MHRA Customer Services <MHRACustomerServices@mhra.gov.uk>
7:01 AM (4 hours ago)
to me
Our Reference: CSC 2028
Dear MJL,
Thank you for providing this information.
Decisions on the use of unlicensed medicine for treatment of patients is made by the healthcare professionals who will decide best treatments going forward for their patient based on their judgement and they do so on their own responsibility.
Kind Regards
Peter
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000
(1)
(0)
